Merck wanted to make Covid-19 vaccines, but its own candidates flopped. In a twist, the drugmaker struck a partnership with rival Johnson & Johnson
Yet if enough doses are made, the vaccine still can play an important role in the pandemic becauseto other shots and J&J’s vaccine is easier to handle and store, public-health advocates and Wall Street analysts say.
“Our vaccine is uniquely positioned to be used in the world,” said Remo Colaruso, J&J’s global manufacturing chief. “The world is not completely vaccinated by a long shot.” During a Jan. 4 call between U.S. officials, Dr. Stoffels and then-Merck Chief Executive Ken Frazier, the companies agreed to assess whether Merck’s plants could adapt to make J&J’s shot, the people said.
“Our issue then became what equipment do we need, where can we get it, how quickly can we get it, is it available, and if not, then what’s our alternatives?” said Mr. McGrath, an industry veteran who joined Merck in 2019. In May, Merck workers discovered another issue with the vials while doing test-runs of the production line using water. They became top-heavy with water when filled. To resolve the issue, a Merck machinist designed a plate that held the containers securely, said Kim Dezura, the West Point plant manager.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Covid Christmas party sends British prime minister into crisis modeBritish PM Johnson is facing growing outrage after a video was leaked suggesting that government staff held a Christmas party at 10 Downing Street last year during a strict lockdown that outlawed social gatherings.
Consulte Mais informação »
Biden’s COVID Vaccine Mandates: Where Do They Stand?Deadlines for COVID-19 vaccine requirements have been shifted, banned, unblocked, and outright protested. Where do vaccine mandates stand now?
Consulte Mais informação »
FDA authorizes Pfizer/BioNTech Covid-19 vaccine boosters for 16- and 17-year-oldsThe US Food and Drug Administration on Thursday authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in people ages 16 and 17. It's the first Covid-19 vaccine booster authorized for this age group in the United States.
Consulte Mais informação »
Amtrak to temporarily cut some service over U.S. COVID-19 vaccine rulesU.S. passenger railroad Amtrak told a U.S. House of Representatives panel on Thursday it expects to be forced to temporarily cut some service in January because of a COVID-19 vaccine mandate.
Consulte Mais informação »
Vaccine makers race to update their COVID shots, just in caseVaccine makers are racing to update their COVID-19 shots to be a better match against the Omicron variant, just in case.
Consulte Mais informação »